首页> 外文期刊>American journal of otolaryngology >Presentation of atrial fibrillation following oral dexamethasone treatment in a NF2 patient
【24h】

Presentation of atrial fibrillation following oral dexamethasone treatment in a NF2 patient

机译:NF2患者口服地塞米松治疗后心房颤动的表现

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Atrial fibrillation (A-fib) is the most common cardiac arrhythmia which is associated with an increased risk of mortality secondary to stroke and coronary artery disease. Intravenous glucocorticoid therapy (such as dexamethasone and hydrocortisone) is frequently used peri-operatively in patients undergoing cardiac surgery to prevent A-fib. Dexamethasone is also frequently used in patients with single or bilateral vestibular schwannomas (VS), to reduce tumor swelling both before and after radiation treatment. We describe a case of A-fib in a 50 year-old female patient with neurofibromatosis type 2 (NF-2), who was prescribed dexamethasone for post-radiation tumor edema.
机译:心房纤颤(A-fib)是最常见的心律不齐,与卒中和冠心病继发的死亡风险增加相关。心脏手术患者通常在围手术期使用静脉糖皮质激素治疗(例如地塞米松和氢化可的松)以预防房颤。地塞米松也常用于患有单发或双侧前庭神经鞘瘤(VS)的患者,以减少放射治疗前后的肿瘤肿胀。我们描述了一名50岁的2型神经纤维瘤病(NF-2)女性患者的房颤病例,该患者被处方地塞米松治疗放射后肿瘤水肿。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号